Northrop Grumman Corporation (NYSE:NOC) has been awarded a follow-on contract by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to create a resource that supports research of pathogenic viruses and that will lead to new medical treatments and preventive measures for humans. Read more here.
|
BRC Websites: EuPathDB | PATRIC | VectorBase | ViPR | ||||||
|
|
|
Northrop Grumman Press Release
No TrackBacks
TrackBack URL: http://pathogenportal.net/cgi-bin/mt/mt-tb.cgi/324
Leave a comment